Vistagen to announce fiscal year 2023 financial results and provide corporate update conference call on june 28, 2023

South san francisco, calif.--(business wire)---- $vtgn #mentalhealth--vistagen (nasdaq: vtgn), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (cns) disorders, today announced it will host a conference call and webcast on wednesday, june 28, at 1:30 p.m. pacific time (4:30 p.m. eastern time) to report results for its fiscal year 2023 ended march 31, 2023 and provide a corporate update. event: vi.
VTGN Ratings Summary
VTGN Quant Ranking